1. Home
  2. IOVA vs FIGR Comparison

IOVA vs FIGR Comparison

Compare IOVA & FIGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$14.11

Market Cap

6.7B

Sector

Health Care

ML Signal

HOLD

Logo Figure Technology Solutions Inc.

FIGR

Figure Technology Solutions Inc.

HOLD

Current Price

$24.08

Market Cap

6.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
FIGR
Founded
2007
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
6.1B
IPO Year
2008
2025

Fundamental Metrics

Financial Performance
Metric
IOVA
FIGR
Price
$14.11
$24.08
Analyst Decision
Buy
Buy
Analyst Count
10
9
Target Price
$14.40
★ $51.56
AVG Volume (30 Days)
★ 12.5M
4.0M
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 14.84
N/A
EPS
N/A
★ 0.53
Revenue
N/A
★ $506,865,000.00
Revenue This Year
$56.63
$109.25
Revenue Next Year
$42.41
$36.72
P/E Ratio
★ N/A
$48.10
Revenue Growth
N/A
★ 48.69
52 Week Low
$1.76
$24.10
52 Week High
$15.37
$78.00

Technical Indicators

Market Signals
Indicator
IOVA
FIGR
Relative Strength Index (RSI) 59.41 33.38
Support Level $3.57 N/A
Resistance Level $15.00 $34.54
Average True Range (ATR) 0.92 1.72
MACD -0.17 -0.18
Stochastic Oscillator 58.17 2.09

Price Performance

Historical Comparison
IOVA
FIGR

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About FIGR Figure Technology Solutions Inc.

Figure Technology Solutions Inc is building the future of capital markets with blockchain technology. proprietary technology powers next-generation lending, trading, and investing activities in areas such as consumer credit and digital assets. Its use of the blockchain ledger allows them to serve their end customers, improve speed and efficiency, and enhance standardization and liquidity. The Company operates as a single operating and reportable segment. The company's geographical operations is within the USA, with the majority of revenue from California.

Share on Social Networks: